The research was led by Vanessa Silva Granadeiro Garcia and Sueli Ivone Borrely of the Instituto de Pesquisas Energéticas e Nucleares (IPEN/CNEN) in São Paulo, working with Lenita de Freitas Tallarico, Maria Clara Feitosa Guimarães, and Eliana Nakano of São Paulo’s Instituto Butantan, and Flávio Kiyoshi Tominaga of the Universidade Federal de São Paulo. Rather than relying on a single model organism — the traditional shortcut of toxicology — the team assembled a battery of four bioassays spanning different branches of the aquatic food web: luminescent bacteria, a planktonic water flea, a bottom-dwelling amphipod crustacean, and a freshwater snail. The strategy reflects a growing conviction in ecotoxicology: a chemical’s true environmental hazard becomes visible only when it is tested against organisms with different body plans, feeding strategies, and life stages. Each organism was exposed to both surfactants across a gradient of concentrations, allowing the researchers to capture acute lethality, chronic reproductive damage, and the subtler sublethal effects that fall short of death yet can quietly erode a population’s ability to persist.

To understand why surfactants are an ecological worry, it helps to examine their molecular architecture. Every surfactant is amphiphilic: one end of the molecule is hydrophilic, or water-loving, while the other end is hydrophobic and shuns water in favor of oils and fats. This split personality is what lets surfactants wedge themselves into the boundary between grease and water, slashing surface tension and emulsifying dirt so it can be rinsed away. But the same property turns destructive once the molecules reach a lake or river. They can insert themselves into the lipid membranes that protect fish gills and invertebrate cells, disturbing ion balance and oxygen exchange, and in high loads they contribute to the depletion of dissolved oxygen and to eutrophication, the nutrient over-enrichment that chokes waterways with algal blooms. LAS, the highest-volume anionic surfactant in household detergents, and SDS, a staple of cleaning products, cosmetics, and laboratory reagents, are both designed to biodegrade — yet field studies cited by the new paper have documented incomplete degradation and lingering residues, including polar LAS metabolites, in surface waters and even in sources of drinking water.

The heart of the study is its carefully chosen cast of test organisms. The bacterium Vibrio fischeri emits light as a byproduct of normal metabolism, so any dimming of its natural glow offers a fast, sensitive readout of metabolic stress; Brazilian and international standards have long used this bioluminescence inhibition assay as a first screen for chemical toxicity. Daphnia similis, a tiny filter-feeding cladoceran, serves as a sentinel of freshwater quality because it sits low in the food web, is easily cultured, and responds quickly to dissolved contaminants. Hyalella azteca, an amphipod crustacean abundant in waterways of the Americas, adds a benthic perspective, since it forages near sediment where pollutants tend to accumulate. Finally, the embryos of the freshwater snail Biomphalaria glabrata develop inside transparent egg capsules, giving researchers a literal window on embryogenesis and an early-warning system for teratogenicity — the capacity of a chemical to produce structural malformations. For each surfactant and each species, the team calculated the E(L)C50: the concentration effective at producing a defined response in fifty percent of exposed organisms, whether that response is loss of bioluminescence, immobilization, or death.

When it came to LAS, the pecking order of vulnerability delivered one of the study’s central lessons. The amphipod Hyalella azteca proved the most sensitive species, followed by the water flea Daphnia similis, the snail Biomphalaria glabrata, and finally the bacteria, with E(L)C50 values falling between 5.04 and 28.47 milligrams per liter. In practical terms, lethality struck half of the exposed amphipods at 5.04 milligrams per liter — the lowest effect concentration recorded for any species against LAS in the study. The crustaceans’ fragility matters far beyond the laboratory bench. Amphipods and cladocerans are the grazing and shredding engine of freshwater food webs, converting algae and decaying detritus into protein for fish and other predators. A surfactant that removes these invertebrates at low doses does not merely kill individuals; it can starve the animals above them, simplify entire communities, and leave ecosystems less resilient to the next stressor.

SDS told a strikingly different story. This time the most sensitive organism was not a crustacean but Vibrio fischeri, whose bioluminescence dimmed at the study’s lowest recorded threshold, just 0.62 milligrams per liter. The water flea came next in sensitivity, followed by the amphipod and the snail, with effect concentrations spanning up to 36.87 milligrams per liter — the widest range recorded for either chemical. The reversal is more than a laboratory curiosity. LAS and SDS are chemical cousins, both anionic surfactants that behave similarly in a stream of washwater, yet their toxicity fingerprints diverge sharply across species. A regulatory framework that leans on a single convenient test organism could, in effect, certify one chemical as acceptably safe while missing entirely the hazard it poses to another branch of the tree of life. The bacteria’s acute sensitivity also carries a practical warning: Vibrio fischeri assays are frequently used as a rapid pre-screen for industrial effluents, and an organism that responds at sub-milligram-per-liter concentrations signals that even trace contamination registers biologically. It is precisely this kind of blind spot that a multi-species battery is designed to illuminate.

Some of the study’s most consequential findings emerged not from acute lethality tests but from longer exposures. When Daphnia similis was kept in water containing either surfactant across its reproductive cycle, the number of offspring it produced declined — a chronic effect that lethality figures alone would never reveal. In daphnids, whose populations surge and collapse in step with water quality, depressed reproduction is a direct forecast of ecological decline, because fewer mothers mean fewer grazers and less food for everything that eats them. The snail embryos delivered perhaps the most unsettling evidence of all: exposure to the surfactants produced both teratogenic and lethal effects, meaning developing animals either emerged malformed or never hatched at all. Because B. glabrata embryos pass through well-characterized developmental stages inside transparent capsules, deformities can be traced to specific windows of morphogenesis, making the snail a powerful model for flagging chemicals that sabotage embryonic development — a hazard class that standard adult toxicity tests routinely overlook.

The findings land in a world already saturated with these compounds. Surfactants are used in detergents, cleaning products, cosmetics, and a vast range of industrial processes, and their journey from drain to river is rarely interrupted completely. Field studies referenced by the Brazilian team have detected LAS in rivers in Brazil, Malaysia, and Poland, have followed its persistence and polar metabolites into drinking water sources, and have measured surfactant-laden effluents from textile mills and municipal treatment plants. Conventional sewage treatment removes a substantial fraction of these chemicals, but degradation is often incomplete, and combined sewer overflows, industrial discharges, and under-treated wastewater can deliver concentrated pulses directly into receiving waters. Remediation researchers have explored answers ranging from ultrafiltration membranes and adsorption onto low-cost materials to advanced oxidation driven by ultraviolet light and hydrogen peroxide, and even concentrated sunlight for surfactant-rich industrial effluents — but no single technology has made surfactant pollution a solved problem. Recent surveys cited in the study go so far as to describe LAS as a neglected traditional pollutant whose threats to surface waters extend to the national scale. Against that backdrop, acute thresholds in the low milligrams per liter range — and sublethal damage to reproduction and development — compress the margin of safety that aquatic ecosystems are assumed to enjoy.

For the study’s authors, the data demonstrate the importance of evaluating surfactant toxicity across multiple species and multiple biological endpoints, precisely because these stressors caused different adverse effects in the exposed organisms. The implications reach into chemical regulation and product design alike. Environmental risk assessments for consumer chemicals have often rested on a small set of standard test species; a battery that includes bacteria, planktonic crustaceans, benthic amphipods, and mollusk embryos captures a far wider swath of biological sensitivity. Sublethal endpoints deserve particular weight in that calculus: a concentration that leaves most of a population alive can still slash its birth rate, and developmental toxicity can echo through generations long after the chemical pulse has passed. As new surfactant chemistries are introduced to replace older formulations, the São Paulo results suggest that every candidate should face the same broad interrogation before it is released into the drain — and that monitoring programs should track not just whether organisms die, but whether they can still reproduce and develop normally.

The work, supported by IPEN/CNEN through the Projeto Intercentros program, by the International Atomic Energy Agency, and by Instituto Butantan, also carries a quieter message that reaches every household. The environmental life of a detergent does not end when the rinse cycle does: every bottle discharges molecules engineered to manipulate water and oil, properties that do not switch off at the end of a pipe. As the new study makes plain, the same chemistry that lifts grease from a dinner plate can dim bacterial light, silence a water flea’s reproduction, and twist a snail embryo out of shape before it ever hatches. The foam may vanish down the drain in seconds, but its biological consequences, the researchers show, keep traveling downstream.

Municipal wastewater treatment commonly relies on activated sludge processes, utilizing microbial communities to degrade organic compounds before releasing treated water back into the environment. However, the biochemical pathways and process conditions that efficiently break down typical organic waste appear insufficient for many pharmaceutical substances, which are chemically and structurally resilient. Due to their partial degradation or persistence, these compounds can pass through treatment plants and enter rivers, lakes, and streams, where they accumulate and may exert ecological effects even at minuscule concentrations.

In their comprehensive study, Chaber-Jarlachowicz’s team sampled influent, activated sludge, and treated effluent from six different wastewater treatment plants across Poland. Their aim was to quantify the removal rates of over a dozen frequently detected pharmaceuticals, including antidepressants, antibiotics, analgesics, antihistamines, and anticonvulsants. Their analysis focused not only on concentration changes but also on estimating the associated ecological risks posed by residual pharmaceutical loads discharged into the aquatic environment after treatment.

Results demonstrated that conventional treatment facilities uniformly failed to eliminate a wide spectrum of pharmaceutical compounds effectively. While some medications such as naproxen and ketoprofen, both non-steroidal anti-inflammatory drugs, and the antihistamine salicylic acid exhibited relatively high removal efficiencies, many others were barely reduced or even experienced concentration increases in treated effluent. Notably, fluoxetine, diclofenac (a pain reliever), and carbamazepine (an anti-seizure medication) were detected at higher levels post-treatment, indicating potential transformation or release mechanisms inherent in the treatment processes themselves.

The presence of elevated concentrations of fluoxetine and loratadine (an allergy medication) in the treated water is particularly concerning due to the compounds’ ability to disrupt endocrine systems and developmental processes in aquatic organisms. These pharmaceuticals tend to mimic or interfere with hormone signaling pathways, which can lead to long-term harmful effects on fish, amphibians, and invertebrates, potentially destabilizing freshwater ecosystems and food webs. Such environmental concentrations, although low, are biologically active and represent a chronic exposure risk that is poorly addressed by current wastewater treatment strategies.

This investigation adds critical evidence confirming previous findings that conventional activated sludge systems are inadequate for pharmaceutical removal. The high emissions—estimated at a minimum of 40 megagrams annually within the studied region—underscore the role of these treatment plants as consistent sources of pharmaceutical contamination. Ketoprofen, sulfamethoxazole (an antibiotic), carbamazepine, and fluoxetine were identified as the dominant contributors to these pharmaceutical loads and subsequent environmental emissions, reinforcing the need for improved technological interventions.

The study’s implications extend beyond local or regional environmental concerns, highlighting a global environmental health crisis linked to the proliferation of pharmaceuticals in natural waters. Current treatment protocols primarily designed for organic waste decomposition lack the specificity and robustness to address synthetic pharmaceutical compounds, many of which possess complex chemical structures resistant to microbial breakdown and standard physicochemical treatment processes.

Moving forward, these findings advocate urgent research into advanced wastewater treatment technologies capable of pharmaceutical compound inactivation and degradation. Emerging approaches such as advanced oxidation processes, membrane filtration, enzyme-based degradation, and bioaugmentation with specialized microbial consortia present promising avenues for reducing pharmaceutical residues in treated wastewater and sludge. However, these methods must be evaluated for feasibility, energy requirements, cost-effectiveness, and secondary environmental impacts to ensure sustainable implementation.

The research also calls for enhanced regulatory frameworks and monitoring protocols to detect and control pharmaceutical pollution more effectively. Identifying priority substances, setting discharge limits, and promoting source control measures—including responsible pharmaceutical disposal and reducing unnecessary medication usage—are essential complementary strategies in mitigating this growing environmental hazard.

The inability to effectively remove pharmaceuticals during conventional municipal wastewater treatment presents an ongoing threat to freshwater ecosystems, aquatic biodiversity, and ultimately human health through contaminated water supplies. These new insights from Poland underscore a pressing need for innovation and policy action to address pharmaceutical emissions, safeguard environmental quality, and ensure the resilience of water resources in the face of increasing pharmaceutical consumption worldwide.

As urban populations and pharmaceutical use continue to grow, the findings by Chaber-Jarlachowicz and colleagues compel renewed attention to one of the less visible but profoundly consequential dimensions of wastewater management—the silent contamination of water bodies with active pharmaceutical ingredients that persist beyond conventional treatment boundaries.

Subject of Research: People
Article Title: Removal efficiency of pharmaceuticals during the wastewater treatment process: Emission and environmental risk assessment
News Publication Date: 24-Sep-2025
Web References: http://dx.doi.org/10.1371/journal.pone.0331211
References: Chaber-Jarlachowicz P, Gworek B, Kalinowski R (2025) Removal efficiency of pharmaceuticals during the wastewater treatment process: Emission and environmental risk assessment. PLoS One 20(9): e0331211.
Image Credits: freestocks, Unsplash, CC0
Keywords: pharmaceutical pollution, wastewater treatment, fluoxetine, carbamazepine, diclofenac, aquatic toxicity, environmental risk, conventional treatment, activated sludge, pharmaceutical persistence

The study conducted by Jack Brand and his team involved a multifaceted approach combining laboratory assays with extensive field experiments to explore how clobazam impacts the physiological and behavioral traits of salmon. The presence of clobazam in the environment has long been a concern, particularly given its efficacy at minimal concentrations, allowing it to persist in natural habitats. The implications of these findings extend beyond the alarming presence of pharmaceuticals in our waterbodies; they signal a complex interplay between chemical exposure and animal behavior that could disrupt vital ecological processes.

Atlantic salmon, known for their remarkable migratory journey from freshwater rivers to the open sea, face various challenges along the way, including natural and man-made barriers such as dams. Clobazam exposure has been found to alter salmon’s navigation efficiency and decision-making processes during migration. Specifically, the research highlights that salmon smolts exposed to this anxiolytic drug exhibited increased risk-taking behavior when encountering hydropower dams, facilitating faster navigation through these critical barriers.

While the increased ability to pass through these constructed obstacles may initially seem advantageous, the researchers warn of the potential trade-offs. For instance, clobazam exposure resulted in a reduction in shoaling behavior. Shoaling is fundamental for salmon, as it provides safety in numbers against predators. The diminished cohesion among salmon groups in the presence of clobazam raises significant concerns about their vulnerability to predation during migration, possibly offsetting any short-term benefits gained from improved navigation.

The ecological consequences of these behavioral changes are profound, urging scientists and conservationists to consider the larger context of pharmaceutical pollution in freshwater environments. As contaminants continue to infiltrate waterways, the question arises: how many more species may be affected in a similar manner, experiencing altered behaviors with ripple effects throughout entire ecosystems?

Understanding these dynamics requires more than just correlational studies; it calls for a comprehensive examination of how various psychoactive substances interact with ecological systems. To this end, Brand and his colleagues have outlined future research projects aiming to delve deeper into this subject. By employing advanced tracking technologies, the team plans to follow the fine-scale movements and behavior of salmon exposed to various concentrations of clobazam and other related compounds in the wild. These high-resolution tracking tools, including miniature biologgers that can record stress levels and detect predation events, will provide invaluable insights into the extent to which pharmaceutical pollution influences predation risk and overall survival of migratory species.

Pharmaceutical pollution is not merely a localized issue; it is a global crisis affecting aquatic biomes from bustling urban centers to remote wilderness areas and even Antarctica. More than 900 pharmaceuticals and their derivatives have been identified in global water systems, a testament to the growing concern surrounding anthropogenic impacts on the environment. How these persistent pollutants interact with wildlife can pose long-term risks not just to biodiversity but also to ecosystem functionality and human health.

As the study demonstrates, even minute concentrations of medications intended for human use can disrupt fundamental survival behaviors in wildlife, amplifying the urgency for evidence-based policies aimed at mitigating these environmental threats. The ramifications of such pollution are particularly concerning for vulnerable species like the Atlantic salmon, whose migratory patterns are critical for maintaining their populations and supporting the broader ecosystem.

In conclusion, the interplay between pharmaceutical pollutants and animal behavior is a burgeoning area of research that deserves immediate attention. Brand’s study not only highlights the intricate connections between contaminants and wildlife but also serves as a clarion call for further investigation into the ecological impacts of human-made substances that infiltrate our waterways. With mounting evidence illustrating the profound effects of these substances, the time for action is now, as policymakers, conservationists, and scientists must collaborate to safeguard our aquatic environments and the species that rely on them.

The findings of this research underscore an urgent need for an integrated approach to environmental management that encompasses pollution prevention, species protection, and habitat conservation. As the world grapples with complex challenges posed by pollution, understanding and addressing the effects of pharmaceutical pollutants is critical for fostering resilient ecosystems and ensuring the sustainability of wildlife populations.

As researchers embark on this journey of discovery, the intricate dance between pharmaceutical compounds and ecological health illuminates a pressing narrative, one that calls each of us to reflect on our responsibility to protect and preserve the natural world amidst the relentless tide of environmental change.

Ultimately, the insights gleaned from this study pave the way for deeper exploration into how human activities reverberate throughout the biosphere. The challenge lies ahead in translating these findings into meaningful action that prioritizes aquatic health and biodiversity in an increasingly polluted world.

Subject of Research: Impact of pharmaceutical pollution on migration behavior in Atlantic salmon
Article Title: Pharmaceutical pollution influences river-to-sea migration in Atlantic salmon (Salmo salar)
News Publication Date: 11-Apr-2025
Web References: http://dx.doi.org/10.1126/science.adp7174
References: N/A
Image Credits: N/A

Keywords: Atlantic salmon, pharmaceutical pollution, clobazam, migration behavior, ecological consequences, freshwater ecosystems, anxiolytic drugs, human impact, biodiversity, environmental management.